
簡要描述:Ulipristal acetate 126784-99-4Ulipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.
產(chǎn)品分類
Product Category相關(guān)文章
Related Articles詳細介紹
| 品牌 | absin | CAS | 126784-99-4 |
|---|---|---|---|
| 分子式 | C30H37NO4 | 純度 | 99% |
| 分子量 | 475.62 | 貨號 | abs47028068 |
| 規(guī)格 | 5mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | is a novel selective progesterone recept | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
Ulipristal acetate 126784-99-4
| 產(chǎn)品描述 | |
| 描述 | Ulipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma. |
| 純度 | 99% |
| 儲存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 可溶性/溶解性 | 10 mM in DMSO |
| 生物活性 | |
| 靶點 | Progesterone receptor |
| In vitro(體外研究) | Ulipristal acetate has partial agonistic as well as antagonistic effects on the progesterone receptor. It also binds to theglucocorticoid receptor, but has no relevant affinity to the estrogen, androgen and mineralocorticoid receptors. |
| In vivo(體內(nèi)研究) | Based on clinical trials, ulipristal acetate seems to be a reasonably tolerable and effective method of emergency contraception when used within 120 hours of intercourse. Ulipristal acetate is at least as effective as LNG when used within the first 72 hours after unprotected intercourse. However, ulipristal acetate may be more effective than LNG when used between 72 to 120 hours after unprotected intercourse, extending the window of opportunity for emergency contraception. |
| 參考文獻 | |
| 參考文獻 |
|
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | CancerSignal transductionNuclear signalingNuclear hormone receptorsProgesterone CancerTumor biomarkersReceptors EpigeneticsNuclear Signaling PathwaysNuclear ReceptorsProgesterone EpigeneticsTranscriptionDomain FamiliesZinc Finger NeuroscienceDevelopment NeuroscienceProcesses NeuroscienceEndocrine systemGonadotrophic axis Signal TransductionSignaling PathwayNuclear SignalingNuclear Hormone ReceptorsProgesterone Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢
